<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00385541</url>
  </required_header>
  <id_info>
    <org_study_id>AAAA2949</org_study_id>
    <nct_id>NCT00385541</nct_id>
  </id_info>
  <brief_title>Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA)</brief_title>
  <official_title>The Comparison of Morphine and Hydromorphone Patient-Controlled Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Both morphine and hydromorphone are pain medications commonly used after surgery. It is
      thought at our institution that hydromorphone causes less side effects but this has not been
      studied. We propose to treat our patients with either morphine or hydromorphone and determine
      how much nausea, vomiting, and itching they have with each drug
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients having general surgery at Columbia University Medical Center that will require
      Patient-Controlled Analgesia Inclusion: 18-60. American Society of Anesthesiologists (ASA)
      1-2 Exclusion, pregnancy, lactation, chronic pain or opioids prior to surgery
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2003</start_date>
  <completion_date type="Actual">October 2007</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nausea Assessment by Patient</measure>
    <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
    <description>Nausea scale range: (0 = none, 10 = the worst), ordinal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Score on the Numeric Rating Scare (NRS) Pruritus Scale</measure>
    <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
    <description>The NRS Pruritus Scale was used to measure magnitude of pruritus (0 = none, 10 = the worst).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Assessment by Patient</measure>
    <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
    <description>Numeric Rating Scale for Pain: (0 = none, 10 = the worst), ordinal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Number of Patients Who Vomited</measure>
    <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Score on the Ramsey Scale of Sedation</measure>
    <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
    <description>The Ramsey scale is used as a measure of sedation from 1 (the patient in anxious and agitated) to 6 (the patient exhibits no response).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive morphine 1mg/dose PCA for postsurgical pain; max 10 mg/hr; lockout 6 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive hydromorphone 0.2mg/dose PCA for postsurgical pain; max 10mg/hr; lockout 6 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine PCA</intervention_name>
    <description>Morphine 1mg/mL, dose 1mL, lockout 6 minutes, max 10mL</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Astramorph PF</other_name>
    <other_name>Duramorph</other_name>
    <other_name>Infumorph</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydromorphone PCA</intervention_name>
    <description>hydromorphone PCA 0.2mg/lml, dose 1ml, lockout 6min, max 10ml</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Dilaudid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients scheduled for abdominal surgery requiring post-operative PCA

          -  ASA = I or II

        Exclusion Criteria:

          -  preoperative pain or use of pain medication

          -  narcotic allergy

          -  morbid obesity (Body Mass Index &gt; 30)

          -  diagnosis of sleep apnea

          -  hepatic or renal disease

          -  use of medications that would affect narcotic pharmacodynamics

          -  preoperative nausea, vomiting, or pruritis

          -  diagnosis of alcoholism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Flood, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia Presbyterian Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hong D, Flood P, Diaz G. The side effects of morphine and hydromorphone patient-controlled analgesia. Anesth Analg. 2008 Oct;107(4):1384-9. doi: 10.1213/ane.0b013e3181823efb.</citation>
    <PMID>18806056</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2006</study_first_submitted>
  <study_first_submitted_qc>October 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2006</study_first_posted>
  <results_first_submitted>July 14, 2010</results_first_submitted>
  <results_first_submitted_qc>August 11, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 31, 2010</results_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2015</last_update_posted>
  <responsible_party>
    <name_title>Pamela Flood MD</name_title>
    <organization>Columbia University</organization>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>morphine</keyword>
  <keyword>hydromorphone</keyword>
  <keyword>nausea</keyword>
  <keyword>vomiting</keyword>
  <keyword>pruritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adults having general surgery at Columbia University Medical Center (CUMC) were randomly assigned to receive Patient-Controlled Analgesia (PCA) with morphine or hydromorphone</recruitment_details>
      <pre_assignment_details>Double blind randomized controlled trial. Patients under 18, with chronic pain or on pain medication before surgery were excluded.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Morphine PCA</title>
          <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
        </group>
        <group group_id="P2">
          <title>Hydromorphone PCA</title>
          <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>severe pain, clinician requested unblind</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Morphine PCA</title>
          <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
        </group>
        <group group_id="B2">
          <title>Hydromorphone PCA</title>
          <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="50"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" spread="12"/>
                    <measurement group_id="B2" value="44" spread="8"/>
                    <measurement group_id="B3" value="42.6" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nausea Assessment by Patient</title>
        <description>Nausea scale range: (0 = none, 10 = the worst), ordinal.</description>
        <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
        <population>Intention to treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Morphine PCA</title>
            <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
          </group>
          <group group_id="O2">
            <title>Hydromorphone PCA</title>
            <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Nausea Assessment by Patient</title>
          <description>Nausea scale range: (0 = none, 10 = the worst), ordinal.</description>
          <population>Intention to treat (ITT)</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="3.2"/>
                    <measurement group_id="O2" value="3.0" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Score on the Numeric Rating Scare (NRS) Pruritus Scale</title>
        <description>The NRS Pruritus Scale was used to measure magnitude of pruritus (0 = none, 10 = the worst).</description>
        <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine PCA</title>
            <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
          </group>
          <group group_id="O2">
            <title>Hydromorphone PCA</title>
            <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Score on the Numeric Rating Scare (NRS) Pruritus Scale</title>
          <description>The NRS Pruritus Scale was used to measure magnitude of pruritus (0 = none, 10 = the worst).</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" spread="0"/>
                    <measurement group_id="O2" value="2.5" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Assessment by Patient</title>
        <description>Numeric Rating Scale for Pain: (0 = none, 10 = the worst), ordinal.</description>
        <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine PCA</title>
            <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
          </group>
          <group group_id="O2">
            <title>Hydromorphone PCA</title>
            <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Assessment by Patient</title>
          <description>Numeric Rating Scale for Pain: (0 = none, 10 = the worst), ordinal.</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="2.3"/>
                    <measurement group_id="O2" value="7.1" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Patients Who Vomited</title>
        <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine PCA</title>
            <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
          </group>
          <group group_id="O2">
            <title>Hydromorphone PCA</title>
            <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Patients Who Vomited</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Score on the Ramsey Scale of Sedation</title>
        <description>The Ramsey scale is used as a measure of sedation from 1 (the patient in anxious and agitated) to 6 (the patient exhibits no response).</description>
        <time_frame>1 hour after surgery, 8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Morphine PCA</title>
            <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
          </group>
          <group group_id="O2">
            <title>Hydromorphone PCA</title>
            <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Score on the Ramsey Scale of Sedation</title>
          <description>The Ramsey scale is used as a measure of sedation from 1 (the patient in anxious and agitated) to 6 (the patient exhibits no response).</description>
          <units>score on scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="0.6"/>
                    <measurement group_id="O2" value="2.8" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Morphine PCA</title>
          <description>Patients receive morphine 1mg/dose pca for postsurgical pain. Max 10mg/hr, lockout 6 minutes</description>
        </group>
        <group group_id="E2">
          <title>Hydromorphone PCA</title>
          <description>Patients receive hydromorphone via PCA at 0.2mg/dose, max 2mg/hr lockout 6 minutes</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This was a small study under typical clinical conditions.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Pamela Flood MD</name_or_title>
      <organization>Columbia University</organization>
      <phone>201-768-8262</phone>
      <email>pdf3@columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

